Oseltamivir-resistant pandemic (H1N1) 2009 in patient with impaired immune system.
作者信息
Hill-Cawthorne Grant A, Schelenz Silke, Lawes Matthew, Dervisevic Samir
出版信息
Emerg Infect Dis. 2010 Jul;16(7):1185-6. doi: 10.3201/eid1607.091579.
Abstract
摘要
相似文献
1
Oseltamivir-resistant pandemic (H1N1) 2009 in patient with impaired immune system.免疫系统受损患者的对奥司他韦耐药的2009年甲型H1N1流感大流行毒株感染病例
Emerg Infect Dis. 2010 Jul;16(7):1185-6. doi: 10.3201/eid1607.091579.
2
[Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus].对奥司他韦耐药的2009年甲型H1N1流感大流行病毒
Ann Fr Anesth Reanim. 2010 Feb;29(2):85-6. doi: 10.1016/j.annfar.2010.01.005.
3
Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case.奥司他韦耐药的大流行（H1N1）2009 流感在一个重症患者中：澳大利亚首例。
Med J Aust. 2010 Feb 1;192(3):166-8. doi: 10.5694/j.1326-5377.2010.tb03459.x.
4
Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea.韩国的奥司他韦耐药大流行（H1N1）2009 病毒。
Emerg Infect Dis. 2010 Dec;16(12):1938-42. doi: 10.3201/eid1612.100600.
5
Community-acquired oseltamivir-resistant pandemic (H1N1) 2009 in child, Israel.以色列儿童中社区获得性对奥司他韦耐药的2009年大流行性（H1N1）流感
Emerg Infect Dis. 2010 Jun;16(6):1045-6. doi: 10.3201/eid1606.091875.
6
Oseltamivir-resistant pandemic H1N1 influenza.对奥司他韦耐药的甲型H1N1流感大流行毒株
CMAJ. 2011 Apr 19;183(7):E420-2. doi: 10.1503/cmaj.100313. Epub 2011 Feb 14.
7
Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.预防期间出现对奥司他韦耐药的大流行性H1N1病毒。
N Engl J Med. 2009 Dec 3;361(23):2296-7. doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11.
8
A severely immunocompromised child with uncomplicated oseltamivir-resistant 2009 H1N1 pandemic influenza infection.一名患有单纯性对奥司他韦耐药的2009年甲型H1N1大流行性流感感染的严重免疫功能低下儿童。
Pediatr Transplant. 2012 Aug;16(5):E158-61. doi: 10.1111/j.1399-3046.2011.01490.x. Epub 2011 Mar 23.
9
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.2009年甲型H1N1流感大流行病毒感染的临床特征
N Engl J Med. 2010 May 6;362(18):1708-19. doi: 10.1056/NEJMra1000449.
10
Oseltamivir resistance in human seasonal influenza viruses (A/H1N1) in EU and EFTA countries: an update.欧盟和欧洲自由贸易联盟国家人类季节性流感病毒（A/H1N1）中的奥司他韦耐药性：最新情况
Euro Surveill. 2008 Feb 7;13(6):8032.
引用本文的文献
1
Drug susceptibility and the potential for drug-resistant SARS-CoV-2 emergence in immunocompromised animals.免疫功能低下动物中药物敏感性及耐药性严重急性呼吸综合征冠状病毒2出现的可能性。
iScience. 2024 Aug 17;27(9):110729. doi: 10.1016/j.isci.2024.110729. eCollection 2024 Sep 20.
2
Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia.澳大利亚悉尼首例大流行期间免疫功能低下个体的 COVID-19 疾病的临床和实验室特征及结局。
PLoS One. 2023 Nov 1;18(11):e0289907. doi: 10.1371/journal.pone.0289907. eCollection 2023.
3
Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: a case report.一名获得性免疫缺陷综合征患者中东呼吸综合征冠状病毒肺炎的成功康复：病例报告
J Clin Virol. 2015 Jan;62:69-71. doi: 10.1016/j.jcv.2014.11.030. Epub 2014 Nov 29.
4
Assessing mathematical models of influenza infections using features of the immune response.利用免疫反应特征评估流感感染的数学模型。
PLoS One. 2013;8(2):e57088. doi: 10.1371/journal.pone.0057088. Epub 2013 Feb 28.
5
Two years after pandemic influenza A/2009/H1N1: what have we learned?大流行性流感 A/2009/H1N1 两年后：我们学到了什么？
Clin Microbiol Rev. 2012 Apr;25(2):223-63. doi: 10.1128/CMR.05012-11.
6
Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.流感和 HIV：2009 年 H1N1 流感大流行的教训。
Curr HIV/AIDS Rep. 2011 Sep;8(3):181-91. doi: 10.1007/s11904-011-0086-4.
7
Systematic review of influenza resistance to the neuraminidase inhibitors.抗流感神经氨酸酶抑制剂耐药性的系统评价。
BMC Infect Dis. 2011 May 19;11:134. doi: 10.1186/1471-2334-11-134.
8
Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.HIV 感染者的流感易感性、严重程度和病毒脱落：文献综述。
Clin Infect Dis. 2011 Jan 15;52(2):219-27. doi: 10.1093/cid/ciq110.
本文引用的文献
1
Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009.2009年，华盛顿州西雅图市两名免疫功能低下患者感染对奥司他韦耐药的新型甲型H1N1流感病毒
MMWR Morb Mortal Wkly Rep. 2009 Aug 21;58(32):893-6.
2
Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses.淋巴细胞减少期间流感病毒的长期感染及耐药病毒的频繁检测。
J Infect Dis. 2009 May 15;199(10):1435-41. doi: 10.1086/598684.
3
Neuraminidase inhibitors for influenza.用于治疗流感的神经氨酸酶抑制剂。
N Engl J Med. 2005 Sep 29;353(13):1363-73. doi: 10.1056/NEJMra050740.
4
Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR.用于常规临床诊断逆转录 - 聚合酶链反应的稳定且非竞争性RNA内参。
J Clin Microbiol. 2004 Mar;42(3):1003-11. doi: 10.1128/JCM.42.3.1003-1011.2004.
5
Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient.一名免疫功能低下患者体内多重耐药甲型流感病毒的长期排毒
N Engl J Med. 2003 Feb 27;348(9):867-8. doi: 10.1056/NEJM200302273480923.
Zotero 插件